About Phil Wilmington
Form D filings for BlueWillow Biologics from 2022 to 2024 list Phil Wilmington as director.
Phil Wilmington first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Phil Wilmington in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Phil Wilmington works with at each company, as listed on that company's latest Form D.
BlueWillow Biologics, Inc. · Form D, Feb 12, 2024
DS
David Stout
Director
RO
Roger D'Orazio
Director
GA
George Arida
Executive officer
HB
Hugo Braun
Director
CC
Chad Costley
President & Chief Executive Officer, director